Clinical Trials

Nasopharyngeal Carcinoma

NCT07567742 2026-05-05

Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma

130 enrolled

Nasopharyngeal Carcinoma, Stomatitis, Ulcer

NCT07565389 2026-05-04

AK112

42 enrolled

Nasopharyngeal Carcinoma

NCT07555860 2026-04-29

Becotatug Vedotin Plus PD-1 Monoclonal Antibody and Radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma

28 enrolled

Phase NA Not yet recruiting

Nasopharyngeal Carcinoma

NCT07552883 2026-04-27

EPoRN

40 enrolled

Phase 3 Not yet recruiting

Nasopharyngeal Carcinoma, Necrosis, Radiation Injuries

NCT07540390 2026-04-22

GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC.

442 enrolled

Phase 1/2 Not yet recruiting

Nasopharyngeal Carcinoma

NCT07247201 2026-03-30

AlloNK1

31 enrolled

Phase 1/2 Not yet recruiting

Nasopharyngeal Carcinoma, Neoplasm, Residual

NCT07320963 2026-03-20

Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.

52 enrolled

Nasopharyngeal Carcinoma

NCT07303283 2026-03-05

Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma

218 enrolled

Nasopharyngeal Carcinoma

NCT07399158 2026-02-10

CROSSROAD: Treatment Regimen Switch - Re-induction Chemotherapy vs. Direct Radiotherapy in LANPC With Inadequate Response to Induction Chemotherapy

223 enrolled

Nasopharyngeal Carcinoma

NCT07388758 2026-02-05

Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal Carcinoma

37 enrolled

Nasopharyngeal Carcinoma

NCT07331428 2026-01-09

MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC

25 enrolled

Nasopharyngeal Carcinoma

NCT05912582 2025-12-26

Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Nasopharyngeal Carcinoma

60 enrolled

Nasopharyngeal Carcinoma

NCT07252375 2025-11-26

A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma

35 enrolled

Nasopharyngeal Carcinoma

NCT07198802 2025-09-30

Molecular Research on Predictive Efficacy and New Therapeutic Targets for Nasopharyngeal Carcinoma

600 enrolled

Nasopharyngeal Carcinoma

NCT07137052 2025-09-17

Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinomar

732 enrolled

Nasopharyngeal Carcinoma

NCT07129772 2025-09-04

Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal Carcinoma

53 enrolled

Nasopharyngeal Carcinoma

NCT07138989 2025-08-24

EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma

10 enrolled

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT07136519 2025-08-22

Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma

30 enrolled

Nasopharyngeal Carcinoma

NCT07110558 2025-08-07

PUPA

59 enrolled

Nasopharyngeal Carcinoma

NCT07088484 2025-07-28

Watch-and-Wait After Immunochemotherapy in Locally Recurrent Nasopharyngeal Carcinoma

50 enrolled

Nasopharyngeal Carcinoma

NCT07064902 2025-07-18

Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

48 enrolled

Phase 3 Not yet recruiting

Nasopharyngeal Carcinoma

NCT07072000 2025-07-18

Shrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal Cavity

550 enrolled